Skip to main content
Erschienen in: Cancer Causes & Control 1/2011

01.01.2011 | Original paper

Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer

verfasst von: K. Nimptsch, S. Kenfield, M. K. Jensen, M. J. Stampfer, M. Franz, L. Sampson, J. C. Brand-Miller, W. C. Willett, E. Giovannucci

Erschienen in: Cancer Causes & Control | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

Insulin may play a role in prostate cancer tumorigenesis. Postprandial blood glucose and insulin responses of foods depend importantly on the carbohydrate quality and quantity, represented by glycemic index (GI), glycemic load (GL), fiber and whole-grain content, but are also influenced by intake of protein and other characteristics. The recently developed insulin index (II) quantifies the postprandial insulin secretion, also taking into account these additional characteristics.

Methods

We investigated the association between dietary GI, GL, II, fiber, and whole grains and risk of total prostate cancer (n = 5,112) and subgroups of prostate cancer as defined by stage or grade in 49,934 male participants of the Health Professionals Follow-up Study. Multivariate adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated using Cox proportional hazards regression.

Results

Dietary GI, GL, II, or fiber was not associated with risk of total or subgroups of prostate cancer. We observed a positive association between dietary intake of whole grains and total prostate cancer (HR highest versus lowest quintile 1.13, 95% CI 1.03–1.24), which was attenuated after restriction to PSA-screened participants (HR 1.03, 95% CI 0.91–1.17).

Conclusions

These results suggest that long-term exposure to a diet with a high insulin response does not affect prostate cancer incidence.
Literatur
1.
Zurück zum Zitat Ferlay J, Bray P, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence mortality and prevalence worldwide. IARC Press, Lyon Ferlay J, Bray P, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence mortality and prevalence worldwide. IARC Press, Lyon
2.
Zurück zum Zitat Chan JM, Stampfer MJ, Giovannucci EL (1998) What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 8(4):263–273CrossRefPubMed Chan JM, Stampfer MJ, Giovannucci EL (1998) What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol 8(4):263–273CrossRefPubMed
3.
Zurück zum Zitat Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60(1):91–106CrossRefPubMed Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60(1):91–106CrossRefPubMed
4.
Zurück zum Zitat Kaaks R (2004) Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262:247–260 (discussion 60–68) Kaaks R (2004) Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262:247–260 (discussion 60–68)
5.
Zurück zum Zitat Nandeesha H (2009) Insulin: a novel agent in the pathogenesis of prostate cancer. Int Urol Nephrol 41(2):267–272CrossRefPubMed Nandeesha H (2009) Insulin: a novel agent in the pathogenesis of prostate cancer. Int Urol Nephrol 41(2):267–272CrossRefPubMed
6.
Zurück zum Zitat Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7):461–471 (W83–W88) Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7):461–471 (W83–W88)
7.
Zurück zum Zitat Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124(10):2416–2429CrossRefPubMed Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124(10):2416–2429CrossRefPubMed
8.
Zurück zum Zitat Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K et al (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101(18):1272–1279CrossRefPubMed Albanes D, Weinstein SJ, Wright ME, Mannisto S, Limburg PJ, Snyder K et al (2009) Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst 101(18):1272–1279CrossRefPubMed
9.
Zurück zum Zitat Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ et al (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68(1):11–19CrossRefPubMed Freedland SJ, Mavropoulos J, Wang A, Darshan M, Demark-Wahnefried W, Aronson WJ et al (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68(1):11–19CrossRefPubMed
10.
Zurück zum Zitat Bao J, de Jong V, Atkinson F, Petocz P, Brand-Miller JC (2009) Food insulin index: physiologic basis for predicting insulin demand evoked by composite meals. Am J Clin Nutr 90(4):986–992CrossRefPubMed Bao J, de Jong V, Atkinson F, Petocz P, Brand-Miller JC (2009) Food insulin index: physiologic basis for predicting insulin demand evoked by composite meals. Am J Clin Nutr 90(4):986–992CrossRefPubMed
11.
Zurück zum Zitat Augustin LS, Galeone C, Dal Maso L, Pelucchi C, Ramazzotti V, Jenkins DJ et al (2004) Glycemic index, glycemic load and risk of prostate cancer. Int J Cancer 112(3):446–450CrossRefPubMed Augustin LS, Galeone C, Dal Maso L, Pelucchi C, Ramazzotti V, Jenkins DJ et al (2004) Glycemic index, glycemic load and risk of prostate cancer. Int J Cancer 112(3):446–450CrossRefPubMed
12.
Zurück zum Zitat George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A et al (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169(4):462–472CrossRefPubMed George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A et al (2009) Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169(4):462–472CrossRefPubMed
13.
Zurück zum Zitat Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L et al (2004) Fibre intake and prostate cancer risk. Int J Cancer 109(2):278–280CrossRefPubMed Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L et al (2004) Fibre intake and prostate cancer risk. Int J Cancer 109(2):278–280CrossRefPubMed
14.
Zurück zum Zitat McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL et al (2005) Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53(1):33–41CrossRefPubMed McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL et al (2005) Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 53(1):33–41CrossRefPubMed
15.
Zurück zum Zitat Lewis JE, Soler-Vila H, Clark PE, Kresty LA, Allen GO, Hu JJ (2009) Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 61(2):216–224CrossRefPubMed Lewis JE, Soler-Vila H, Clark PE, Kresty LA, Allen GO, Hu JJ (2009) Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 61(2):216–224CrossRefPubMed
16.
Zurück zum Zitat Suzuki R, Allen NE, Key TJ, Appleby PN, Tjonneland A, Johnsen NF et al (2009) A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC. Int J Cancer 124(1):245–249CrossRefPubMed Suzuki R, Allen NE, Key TJ, Appleby PN, Tjonneland A, Johnsen NF et al (2009) A prospective analysis of the association between dietary fiber intake and prostate cancer risk in EPIC. Int J Cancer 124(1):245–249CrossRefPubMed
17.
Zurück zum Zitat Chatenoud L, Tavani A, La Vecchia C, Jacobs DR Jr, Negri E, Levi F et al (1998) Whole grain food intake and cancer risk. Int J Cancer 77(1):24–28CrossRefPubMed Chatenoud L, Tavani A, La Vecchia C, Jacobs DR Jr, Negri E, Levi F et al (1998) Whole grain food intake and cancer risk. Int J Cancer 77(1):24–28CrossRefPubMed
18.
Zurück zum Zitat Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM et al (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34(3):362–366PubMed Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM et al (1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34(3):362–366PubMed
19.
Zurück zum Zitat Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76(1):5–56PubMed Foster-Powell K, Holt SH, Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76(1):5–56PubMed
20.
Zurück zum Zitat Holt SH, Miller JC, Petocz P (1997) An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 66(5):1264–1276PubMed Holt SH, Miller JC, Petocz P (1997) An insulin index of foods: the insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 66(5):1264–1276PubMed
21.
Zurück zum Zitat Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Gronbaek M et al (2004) Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr 80(6):1492–1499PubMed Jensen MK, Koh-Banerjee P, Hu FB, Franz M, Sampson L, Gronbaek M et al (2004) Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr 80(6):1492–1499PubMed
22.
Zurück zum Zitat USDA National Nutrient Database for Standard Reference (2004) Release 17. Agricultural Research Service, Washington, DC USDA National Nutrient Database for Standard Reference (2004) Release 17. Agricultural Research Service, Washington, DC
23.
Zurück zum Zitat Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165(9):1005–1010CrossRefPubMed Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med 165(9):1005–1010CrossRefPubMed
24.
Zurück zum Zitat Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ (2003) Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95(16):1240–1244CrossRefPubMed Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ (2003) Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst 95(16):1240–1244CrossRefPubMed
25.
Zurück zum Zitat Platz EA, Leitzmann MF, Michaud DS, Willett WC, Giovannucci E (2003) Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res 63(23):8542–8548PubMed Platz EA, Leitzmann MF, Michaud DS, Willett WC, Giovannucci E (2003) Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res 63(23):8542–8548PubMed
26.
Zurück zum Zitat Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ et al (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20(4):545–550CrossRefPubMed Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ et al (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20(4):545–550CrossRefPubMed
27.
Zurück zum Zitat Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277(6):472–477CrossRefPubMed Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277(6):472–477CrossRefPubMed
28.
Zurück zum Zitat Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB (2004) Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 80(2):348–356PubMed Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB (2004) Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 80(2):348–356PubMed
29.
Zurück zum Zitat Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S et al (2007) Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16(6):1121–1127CrossRefPubMed Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S et al (2007) Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16(6):1121–1127CrossRefPubMed
30.
Zurück zum Zitat Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC et al (2010) Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993–2004. Int J Cancer Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC et al (2010) Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993–2004. Int J Cancer
31.
Zurück zum Zitat Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M et al (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94(14):1099–1106PubMed Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M et al (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94(14):1099–1106PubMed
32.
Zurück zum Zitat Rohan TE, Howe GR, Burch JD, Jain M (1995) Dietary factors and risk of prostate cancer: a case–control study in Ontario, Canada. Cancer Causes Control 6(2):145–154CrossRefPubMed Rohan TE, Howe GR, Burch JD, Jain M (1995) Dietary factors and risk of prostate cancer: a case–control study in Ontario, Canada. Cancer Causes Control 6(2):145–154CrossRefPubMed
33.
Zurück zum Zitat Jensen MK, Koh-Banerjee P, Franz M, Sampson L, Gronbaek M, Rimm EB (2006) Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 83(2):275–283PubMed Jensen MK, Koh-Banerjee P, Franz M, Sampson L, Gronbaek M, Rimm EB (2006) Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1. Am J Clin Nutr 83(2):275–283PubMed
34.
Zurück zum Zitat Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE et al (2001) Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 73(3):560–566PubMed Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE et al (2001) Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 73(3):560–566PubMed
35.
Zurück zum Zitat Wu T, Giovannucci E, Pischon T, Hankinson SE, Ma J, Rifai N et al (2004) Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr 80(4):1043–1049PubMed Wu T, Giovannucci E, Pischon T, Hankinson SE, Ma J, Rifai N et al (2004) Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr 80(4):1043–1049PubMed
36.
Zurück zum Zitat Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA et al (2002) Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 76(3):535–540PubMed Fung TT, Hu FB, Pereira MA, Liu S, Stampfer MJ, Colditz GA et al (2002) Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 76(3):535–540PubMed
37.
Zurück zum Zitat Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915–928CrossRefPubMed Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915–928CrossRefPubMed
38.
Zurück zum Zitat Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003) Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95(1):67–71CrossRefPubMed Hsing AW, Gao YT, Chua S Jr, Deng J, Stanczyk FZ (2003) Insulin resistance and prostate cancer risk. J Natl Cancer Inst 95(1):67–71CrossRefPubMed
39.
Zurück zum Zitat Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH et al (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92(23):1910–1917CrossRefPubMed Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH et al (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92(23):1910–1917CrossRefPubMed
40.
Zurück zum Zitat Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039–1047CrossRefPubMed Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al (2008) Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 9(11):1039–1047CrossRefPubMed
41.
Zurück zum Zitat Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B et al (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120(12):2678–2686CrossRefPubMed Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B et al (2007) Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden. Int J Cancer 120(12):2678–2686CrossRefPubMed
42.
Zurück zum Zitat Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P (2008) Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87(6):1793–1801PubMed Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P (2008) Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87(6):1793–1801PubMed
Metadaten
Titel
Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer
verfasst von
K. Nimptsch
S. Kenfield
M. K. Jensen
M. J. Stampfer
M. Franz
L. Sampson
J. C. Brand-Miller
W. C. Willett
E. Giovannucci
Publikationsdatum
01.01.2011
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9671-x

Weitere Artikel der Ausgabe 1/2011

Cancer Causes & Control 1/2011 Zur Ausgabe

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.